Unique biochemical properties of human leukocyte antigen-E allow for a highly specific function in immune recognition

American Journal of Reproductive Immunology

Volumn 40, Issue 3, 1998, Pages 177-182

  Weiss, Elisabeth H ^a,c   Cannich, Astrid ^a   Sprinks, Matthew ^b   Fernandez, Nelson ^b   Ulbrecht, Matthias ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY OF ESSEX   (United Kingdom)

^c Institut fur Anthropologie und Humangenetik   (Germany)

Author keywords

Antigen presentation; HLA E; Peptides; 2 microglobulin

Indexed keywords

BETA 2 MICROGLOBULIN; HLA A ANTIGEN; HLA ANTIGEN CLASS 1; LEUKOCYTE ANTIGEN; LIGAND; PEPTIDE;

ANIMAL CELL; ANTIGEN PRESENTATION; ANTIGEN RECOGNITION; ARTICLE; BIOCHEMISTRY; EFFECTOR CELL; HUMAN; IMMUNOPRECIPITATION; ISOELECTRIC FOCUSING; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0031854108     PISSN: 87558920     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0897.1998.tb00410.x     Document Type: Article

References (35)

1. Townsend AR, Gotch FM, Davey J: Cytotoxic T cells recognize fragments of the influenza nucleoprotein. Cell 1985; 42:457-467.
2. Germain R: MHC-dependent antigen processing and peptide presentation: Providing ligands for lymphocyte activation. Cell 1994; 76:287-299.
3. Kärre K, Ljunggren HG, Piontek G, Kiessling R: Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defence strategy. Nature 1986; 319:675-678.
4. Ljunggren HG, Kärre K: In search of the "missing self": MHC molecules and NK cell recognition. Immunol Today 1990; 11:237-243.
5. Lanier LL: Natural killer cells: From no receptors to too many. Immunity 1997; 6:371-378.
6. Reyburn H, Mandelboim O, Vales-Gomez M, Sheu EG, Pazmany L, Davis DM, et al.: Human NK cells: Their ligands, receptors and functions. Immunol Rev 1997; 155:119-125.
7. Suh W-K, Cohen Doyle MF, Fruh K, Wang K, Peterson PA, Williams DB: Interaction of MHC class I molecules with the transporter associated with antigen processing. Science 1994; 264:1322-1326.
8. 2-microglobulin complexes associate with TAP transporters before peptide binding. Nature 1994; 368:864-867.
9. Jackson MR, Cohen Doyle MF, Peterson PA, Williams DB: Regulation of MHC class I transport by the molecular chaperone, calnexin (p88, IP90). Science 1994; 263:384-387.
10. Sadasivan B, Lehner PJ, Ortmann B, Spies T, Cresswell P: Roles for calreticulin and a novel glycoprotein, tapasin, in the interaction of MHC class I molecules with TAP. Immunity 1996; 5:103-114.
11. Nössner E, Parham P: Species-specific differences in chaperon interaciton of human and mouse major histocompatibility complex class I molecules. J Exp Med 1995; 181:327-337.
12. Hughes EA, Hammond C, Cresswell P: Misfolded major histocompatibility complex class I heavy chains are translocated into the cytoplasm and degraded by the proteasome. Proc Natl Acad Sci USA 1997; 94:1896-1901.
13. Ulbrecht M, Honka T, Person S, Johnson JP, Weiss EH: The HLA-E gene encodes two differentially regulated transcripts and a cell surface protein. J Immunol 1992; 149:2945-2953.
14. Ulbrecht M, Kellermann J, Johnson JP, Weiss EH: Impaired intracellular transport and cell surface expression of nonpolymorphic HLA-E: Evidence for inefficient peptide binding. J Exp Med 1992; 176:1083-1090.
15. Ulbrecht M, Modrow S, Srivastava R, Peterson PA, Weiss EH: Interaction of HLA-E with peptides and the peptide transporter in vitro: Implications for its function in antigen presentation. J Immunol 1998; 160:4375-4385.
16. Braud V, Jones EY, McMichael A: The human major histocompatibility complex class Ib molecule HLA-E binds signal sequence derived peptides with primary anchor residues at positions 2 and 9. Eur J Immunol 1997; 27:1164-1169.
17. 2-microglobulin specifically enhances cell-surface expression of HLA class I molecules in transfected murine cells. J Immunol 1988; 141:1383-1389.
18. Ohya AC, Kondo K, Mizuno S: Polymorphism in the human class I MHC locus HLA-E in Japanese. Immunogenetics 1990; 32:205-209.
19. Fernandez N, Labeta M, Kurpisz M, Nakatsuji T, Sachs J, Festenstein H: Major histocompatibility complex (MHC) protein analysis by optimised two-dimensional electrophoretic methods. Electrophoresis 1990; 11:167-174.
20. Yang SY: A standardized method for detection of HLA-A and HLA-B alleles by one-dimensional isoelectric focusing (IEF) gel electrophoresis. In Immunobiology of HLA, B Dupont (ed). New York, Springer, 1989, pp 332-335.
21. Koller BH, Geraghty DE, Shimizu Y, DeMars R, Orr HT: HLA-E. A novel HLA class I gene expressed in resting T lymphocytes. J Immunol 1988; 141:897-904.
22. Wei XH, Orr HT: Differential expression of HLA-E, HLA-F, and HLA-G transcripts in human tissue. Hum Immunol 1990; 29:131-142.
23. Houlihan JM, Biro PA, Fergar Payne A, Simpson KL, Holmes CH: Evidence for the expression of non-HLA-A, -B, -C class I genes in the human fetal liver. J Immunol 1992; 149:668-675.
24. Houlihan JM, Biro PA, Harper HM, Jenkinson HJ, Holmes CH: The human amnion is a site of MHC class Ib expression: Evidence for the expression of HLA-E and HLA-G. J Immunol 1995; 154:5665-5674.
25. Fiszer D, Ulbrecht M, Fernandez N, Johnson JP, Weiss EH, Kurpisz M: Analysis of HLA class Ib gene expression in male gametogenic cells. Eur J Immunol 1997; 27:1691-1695.
26. Rinke de Wit TF, Vloemans S, van den Eisen PJ, Haworth A, Stern PL: Differential expression of the HLA class I multigene family by human embryonal carcinoma and choriocarcinoma cell lines. J Immunol 1990; 144:1080-1087.
27. Braud VM, Allan DSJ, Wilson D, McMichael AJ: TAP- and tapasin-dependent HLA-E surface expression correlates with the binding of an MHC class I leader peptide. Curr Biol 1997; 8:1-10.
28. Schmidt CM, Orr HT: Maternal/fetal interaction: The role of the MHC class I molecule HLA-G. Crit Rev Immunol 1993; 13:207-224.
29. Mandelboim O, Pazmany L, Davis DM, Vales-Gomez M, Reyburn HT, Rybalov B, et al.: Multiple receptors for HLA-G on human natural killer cells. Proc Natl Acad Sci USA.
30. Pazmany L, Mandelboim O, Vales-Gomez M, Davis DM, Reyburn HT, Strominger JL: Protection from natural killer cell-mediated lysis by HLA-G expression on target cells. Science 1996; 274:792-795.
31. Münz C, Holmes N, King A, Loke YW, Colonna M, Schild H, et al.: Human histocompatibility leukocyte antigen (HLA)-G molecules inhibit NKAT3 expressing natural killer cells. J Exp Med 1997; 185:385-391.
32. Perez Villar JJ, Melero I, Navarro F, Carretero M, Bellon T, Llano M, et al.: The CD94/NKG2-A inhibitory receptor complex is involved in natural killer cell-mediated recognition of cells expressing HLA-G1. J Immunol 1997; 158:5736-5743.
33. Borrego F, Ulbrecht M, Weiss EH, Coligan JE, Brooks AG: Recognition of HLA-E complexed with HLA- class I signal sequence-derived peptides by CD94/NKG2 confers protection from NK cell mediated lysis. J Exp Med 1998; 187:813-818.
34. Braud VM, Allan DS, O'Callaghan CA, Söderström K, D'Andrea A, Ogg GS, et al.: HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C. Nature 1998; 391:795-799.
35. Houchins JP, Lanier LL, Niemi EC, Phillips JH, Ryan JC: Natural killer cell cytolytic activity is inhibited by NKG2-A and activated by NKG2-C. J Immunol 1997; 158:3603-3609.